Table 2. Follow-up protocol for CHAMP.
Evaluation | Baseline | MSC Injection | BKA (Day varies) | Day 3 | Day 14 | Day 45 | Week 12 | Week 18 | Week 24 |
---|---|---|---|---|---|---|---|---|---|
Informed Consent | X | ||||||||
Medical History | X | ||||||||
Physical Exam | X | X | X | X | X | X | X | X | X |
Vital Signs | X | X | X | X | X | X | X | X | X |
Medication List | X | X | X | X | X | X | X | X | |
Serum Pregnancy Test | X | ||||||||
Adverse Event Evaluation | X | X | X | X | X | X | X | X | X |
Infectious Disease Labs | X | ||||||||
General Labs | X | X | X | X | X | X | |||
12-Lead EKG | X | X | X | X | X | X | |||
Lower Extremity Arterial Duplex | X | ||||||||
Randomization: Time to BKA | X |